Amblyz™ glasses represent a totally new approach in the treatment of amblyopia. The electronic device, shaped like glasses, is easy to use, comfortable, efficient and made for children from 3 – 10 years of age.
Using intermittent occlusion of the healthy eye, Amblyz™ glasses force the development of the amblyopic eye without pain, discomfort or the stigma associated with existing therapies, such as an eye patch.
In addition, patients diagnosed with an amblyopic eye usually require perscription glasses; Amblyz™ glasses however can serve as an amblyopia therapy and prescription glasses at the same time.
XPAND is presenting Amblyz™ Glasses at WOC in Guadalajara between February 5 and 9.
We are looking forward to meeting you at booth No. 927.
Researchers present findings on first new therapy for childhood amblyopia in 50 years at AAO 2015, American Academy of Ophthalmology’s annual meeting
A new study on lazy eye found that programmable electronic glasses help improve vision in children just as well as the more traditional treatment using eye patches. This “digital patch” is the first new effective treatment for lazy eye in half a century, read the full text >>
XPAND Amblyz™ Cleared for Sale in the U.S. by the FDA
In the U.S., Amblyz™ glasses are available from the Good-Lite Company. For more information on Amblyz™ glasses, or to order please visit: www.good-lite.com
Please check out the ever growing list of our distributors!